Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Niranjan

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Preventive Medicine Reports|March 6, 2023
Provision of smoking cessation support for patients following a diagnosis of cancer in IrelandP Fitzpatrick, N Bhardwaj, M Masalkhi, et al.
SAR and QSAR in Environmental Research|January 8, 2025
Unveiling the potential of Hamigeran-B from marine sponges as a probable inhibitor of Nipah virus RDRP through molecular modelling and dynamics simulation studiesS Skariyachan, A Jayaprakash, J J Kelambeth, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Preventive Medicine Reports|March 6, 2023
Provision of smoking cessation support for patients following a diagnosis of cancer in IrelandP Fitzpatrick, N Bhardwaj, M Masalkhi, et al.
SAR and QSAR in Environmental Research|January 8, 2025
Unveiling the potential of Hamigeran-B from marine sponges as a probable inhibitor of Nipah virus RDRP through molecular modelling and dynamics simulation studiesS Skariyachan, A Jayaprakash, J J Kelambeth, et al.
Clinical Pharmacology and Therapeutics|May 29, 2014
The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approachM A Kamal, E P Acosta, D W Kimberlin, et al.
Pageof 2